MD FACC - GRPH Old CEO Pres
Insider
MD FACC is CEO Pres of GRPH Old
| Age | 50 |
| Phone | 650 484 0886 |
| Web | https://graphitebio.com |
GRPH Old Management Efficiency
The company has return on total asset (ROA) of (0.1799) % which means that it has lost $0.1799 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5195) %, meaning that it created substantial loss on money invested by shareholders. GRPH Old's management efficiency ratios could be used to measure how well GRPH Old manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 362 K in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. GRPH Old has a current ratio of 26.53, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist GRPH Old until it has trouble settling it off, either with new capital or with free cash flow. So, GRPH Old's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like GRPH Old sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for GRPH to invest in growth at high rates of return. When we think about GRPH Old's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Michelle Doig | Nuvation Bio | 46 | |
| Dr IV | Assembly Biosciences | 52 | |
| Michele Anderson | Assembly Biosciences | N/A | |
| Steven Fuller | Sensei Biotherapeutics | N/A | |
| FMEDSCI MD | Achilles Therapeutics PLC | 49 | |
| Sergey Yurasov | Nuvation Bio | 51 | |
| Robert Coutts | Achilles Therapeutics PLC | 40 | |
| Kerry Wentworth | Nuvation Bio | 51 | |
| Lieping MD | NextCure | 66 | |
| MD FACP | NextCure | 71 | |
| Gary Hattersley | Nuvation Bio | 57 | |
| Thomas Templeman | Nuvation Bio | 60 | |
| Hoyoung MD | CytomX Therapeutics | 55 | |
| Karl MD | Achilles Therapeutics PLC | 57 | |
| MHROD SHRMSCP | Assembly Biosciences | N/A | |
| Fazal Khan | Merrimack Pharmaceuticals | 74 | |
| Daniel Welch | Nuvation Bio | 63 | |
| MBA MBA | Sensei Biotherapeutics | 52 | |
| David MD | Nuvation Bio | 54 | |
| DPHIL DPhil | CytomX Therapeutics | 57 | |
| Solomon Langermann | NextCure | 64 | |
Management Performance
| Return On Equity | -0.52 | |||
| Return On Asset | -0.18 |
GRPH Old Leadership Team
Elected by the shareholders, the GRPH Old's board of directors comprises two types of representatives: GRPH Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GRPH. The board's role is to monitor GRPH Old's management team and ensure that shareholders' interests are well served. GRPH Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GRPH Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yehuda Eliraz, Director | ||
| Stephanie Yao, Vice Relations | ||
| Christine PMP, Chief Operations | ||
| Jerry Cacia, Chief Officer | ||
| Charles Maslin, COO | ||
| MD FACC, CEO Pres | ||
| Alethia Young, Chief Officer | ||
| Matthew MD, Academic Director | ||
| Mark Radom, CEO and President CFO, Treasurer and Director | ||
| Maria MD, Academic Board | ||
| Philip Gutry, Chief Officer | ||
| Jane Grogan, Chief Officer | ||
| Daniel Dever, CoFounder Research | ||
| Kimberlee CPA, CEO and Presidentident |
GRPH Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is GRPH Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.52 | |||
| Return On Asset | -0.18 | |||
| Current Valuation | 1.88 M | |||
| Shares Outstanding | 58.24 M | |||
| Shares Owned By Insiders | 9.17 % | |||
| Shares Owned By Institutions | 84.40 % | |||
| Number Of Shares Shorted | 704.04 K | |||
| Price To Earning | 0.70 X | |||
| Price To Book | 1.01 X | |||
| EBITDA | (70.7 M) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards GRPH Old in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, GRPH Old's short interest history, or implied volatility extrapolated from GRPH Old options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in GRPH Stock
If you are still planning to invest in GRPH Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GRPH Old's history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |